34200-00-5 Usage
Derivative of isoxazole group
Yes
The compound is derived from the isoxazole group, which is a five-membered aromatic ring containing an oxygen and nitrogen atom at adjacent positions.
Methoxy group attachment
Benzo[d]isoxazol-3-yl moiety
A methoxy group (-OCH3) is attached to the benzo[d]isoxazol-3-yl part of the molecule, which may influence its chemical reactivity and properties.
Contains an acetic acid group
Yes
The compound also contains an acetic acid group (-COOH), which is a carboxyl group commonly found in organic chemistry.
Potential use in pharmaceutical research
Yes
Due to its unique chemical structure, 2-(6-METHOXYBENZO[D]ISOXAZOL-3-YL)ACETIC ACID may have potential applications in pharmaceutical research and drug development.
Pharmacological properties
Unknown
Further studies are needed to fully understand the biological activities and potential pharmacological properties of 2-(6-METHOXYBENZO[D]ISOXAZOL-3-YL)ACETIC ACID.
Drug development
Potential
The compound may be useful in the development of new drugs, but more research is required to determine its efficacy and safety.
Further studies needed
Yes
To fully elucidate the biological activities, potential applications, and safety profile of 2-(6-METHOXYBENZO[D]ISOXAZOL-3-YL)ACETIC ACID, additional research and experimentation are necessary.
Check Digit Verification of cas no
The CAS Registry Mumber 34200-00-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,4,2,0 and 0 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 34200-00:
(7*3)+(6*4)+(5*2)+(4*0)+(3*0)+(2*0)+(1*0)=55
55 % 10 = 5
So 34200-00-5 is a valid CAS Registry Number.
34200-00-5Relevant academic research and scientific papers
1,2-Benzisoxazole Phosphorodiamidates as Novel Anticancer Prodrugs Requiring Bioreductive Activation
Jain, Monish,Kwon, Chul-Hoon
, p. 5428 - 5436 (2007/10/03)
Several 1,2-benzisoxazole phosphorodiamidates have been designed as prodrugs of phosphoramide mustard requiring bioreductive activation. Enzymatic reduction of 1,2-benziosoxazole moiety is expected to result in the formation of imine intermediate due to t
